Prediction of progression in pTa and pTI bladder carcinomas with p53, p16 and pRb
dc.contributor.author | Hitchings, AW | en_US |
dc.contributor.author | Kumar, M | en_US |
dc.contributor.author | Jordan, S | en_US |
dc.contributor.author | Nargund, V | en_US |
dc.contributor.author | Martin, J | en_US |
dc.contributor.author | Berney, DM | en_US |
dc.date.accessioned | 2019-04-04T11:01:53Z | |
dc.date.issued | 2004-08-02 | en_US |
dc.identifier.issn | 0007-0920 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/56698 | |
dc.format.extent | 552 - 557 | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | BRIT J CANCER | en_US |
dc.rights | All rights reserved | |
dc.subject | transitional cell carcinoma | en_US |
dc.subject | immunohistochemistry | en_US |
dc.subject | molecular markers | en_US |
dc.subject | prognosis | en_US |
dc.subject | RETINOBLASTOMA PROTEIN EXPRESSION | en_US |
dc.subject | TRANSITIONAL-CELL CARCINOMA | en_US |
dc.subject | CANCER PROGRESSION | en_US |
dc.subject | TUMOR RECURRENCE | en_US |
dc.subject | MUTATIONS | en_US |
dc.subject | GRADE | en_US |
dc.subject | GENE | en_US |
dc.subject | IMMUNOHISTOCHEMISTRY | en_US |
dc.subject | ACCUMULATION | en_US |
dc.subject | PATHWAY | en_US |
dc.title | Prediction of progression in pTa and pTI bladder carcinomas with p53, p16 and pRb | en_US |
dc.type | Article | |
dc.rights.holder | 2004 Cancer Research UK | |
dc.identifier.doi | 10.1038/sj.bjc.6601954 | en_US |
pubs.issue | 3 | en_US |
pubs.notes | Not known | en_US |
pubs.volume | 91 | en_US |
rioxxterms.funder | Default funder | en_US |
rioxxterms.identifier.project | Default project | en_US |